Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3751-3755
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3751
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3751
Serum and urine amylaseactivity levels | Control group(%) | ACC group(%) | P |
before ERCP serum | 62.1 ± 59.7 | 79.0 ± 79.4 | NS |
urine | 272.9 ± 320.5 | 268.1 ± 355.2 | NS |
8 h after ERCP serum | 324.6 ± 487.1 | 270.1 ± 484.7 | NS |
urine | 596.3 ± 1108.3 | 775.9 ± 1500.4 | NS |
24 h after ERCP serum | 268.6 ± 590.9 | 183.56 ± 252.1 | NS |
urine | 1324.8 ± 2763.9 | 1033.7 ± 2499.6 | NS |
- Citation: Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 2006; 12(23): 3751-3755
- URL: https://www.wjgnet.com/1007-9327/full/v12/i23/3751.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i23.3751